pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
1,831
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Preclinical
FID-023
Leukemia
Fulgent Pharma LLC
0
catalysts
Preclinical
FID-025
Brain Cancer
Fulgent Pharma LLC
0
catalysts
Phase 2
FKPC-101
Metastatic Prostate Cancer
CellVax Therapeutics Inc
0
catalysts
Preclinical
FLAG-003
Pediatric Diffuse Intrinsic Pontine Glioma
Flag Therapeutics Inc
← prev
page 19 of 62
next →
131
Pain
89
Neurology
1
0
catalysts
Preclinical
FLAG-094
Malignant Mesothelioma
Flag Therapeutics Inc
0
catalysts
Preclinical
FMC-220
Solid Tumor
LG Chem Ltd
0
catalysts
Phase 1
FORX-428
Metastatic Breast Cancer
FoRx Therapeutics AG
0
catalysts
Phase 1
FPI-2068
Metastatic Colorectal Cancer
Fusion Pharmaceuticals Inc
0
catalysts
Phase 2
FPI-2265
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Fusion Pharmaceuticals Inc
0
catalysts
Phase 1
FS-120
Advanced Malignancy
invoX Pharma Ltd
0
catalysts
Preclinical
FT-002a-O
Castration-Resistant Prostate Cancer (CRPC)
AecorBio Inc
0
catalysts
Phase 1
FT-522
B-Cell Non-Hodgkin Lymphoma
$FATE
FATE THERAPEUTICS INC
0
catalysts
Phase 1
FT-576
Refractory Multiple Myeloma
$FATE
FATE THERAPEUTICS INC
0
catalysts
Phase 1
FT-819
Idiopathic Inflammatory Myopathy (IIM)
$FATE
FATE THERAPEUTICS INC
0
catalysts
Phase 1
FT-825
Colorectal Cancer
$FATE
FATE THERAPEUTICS INC
0
catalysts
Phase 1
FT-836
Breast Cancer
$FATE
FATE THERAPEUTICS INC
0
catalysts
Preclinical
FT-839
Hematological Tumor
$FATE
FATE THERAPEUTICS INC
0
catalysts
Preclinical
FT-8XX
Unspecified Cancer
$FATE
FATE THERAPEUTICS INC
0
catalysts
Phase 2
FWD-1802
Metastatic Breast Cancer
Shenzhen Forward Pharmaceutical Co Ltd
0
catalysts
Phase 1
G-207
Anaplastic Astrocytoma
Treovir LLC
0
catalysts
Preclinical
G2B-002
Malignant Glioma
Gate2Brain SL
0
catalysts
Preclinical
GADLEN Multiple-CD20
Unspecified Cancer
$STTK
Shattuck Labs, Inc.
0
catalysts
Preclinical
GB-13
Pediatric Diffuse Intrinsic Pontine Glioma
Targepeutics Inc
0
catalysts
Preclinical
GB-264
Gastrointestinal Tumor
Genor BioPharma Co Ltd
0
catalysts
Preclinical
GB-266
Unspecified Cancer
Genor BioPharma Co Ltd
0
catalysts
Preclinical
GCC-2004
B-Cell Non-Hodgkin Lymphoma
$ARTV
Artiva Biotherapeutics, Inc.
0
catalysts
Phase 2
GCC-4001
Idiopathic Inflammatory Myopathy (IIM)
$ARTV
Artiva Biotherapeutics, Inc.
0
catalysts
Phase 2
GD2-SADA-177Lu-Proteus
Melanoma
Y-mAbs Therapeutics Inc
0
catalysts
Preclinical
GDT-002
Pancreatic Ductal Adenocarcinoma
Guidant Biotherapeutics Corp
0
catalysts
Preclinical
GEO-MVA-MUC1
Breast Cancer
$GOVX
GeoVax Labs, Inc.
0
catalysts
